|
Sign In to gain access to subscriptions and/or personal tools.
|
Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis
Andrew H. Briggs
Alastair M. Gray
As the data for economic analyses are increasingly collected prospectively alongside clinical trials, many commentators have highlighted that the sample sizes in such trials should be based on the requirements for the economic analysis as well as those for the clinical evaluation. However, issues associated with sample size calculations for economic analysis have yet to receive the rigorous attention given to sample size calculation for clinical evaluation. In particular, no sample size formula for cost-ef fectiveness analysis is available for analysts hoping either to calculate the required sample size at the design stage of a study or to calculate the power a given size of clinical trial will generate for cost-effectiveness analysis. Building on the recent liter ature for calculating confidence intervals for cost-effectiveness ratios, the authors ex plore possible techniques for deriving a sample size formula for cost-effectiveness analysis based on simple combination of the confidence limits on costs and effects. Key words: cost-effectiveness; economic analysis; sample size; methodology. (Med Decis Making 1998;18 suppl:S81-S92)
Medical Decision Making, Vol. 18, No. 2,
S81-S92 (1998)
DOI: 10.1177/0272989X9801800210

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A O'Hagan and J W Stevens
Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies
Statistical Methods in Medical Research,
December 1, 2002;
11(6):
469 - 490.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A R Willan, D Y Lin, R J Cook, and E B Chen
Using inverse-weighting in cost-effectiveness analysis with censored data
Statistical Methods in Medical Research,
December 1, 2002;
11(6):
539 - 551.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O'Hagan and J. W. Stevens
Bayesian Assessment of Sample Size for Clinical Trials of Cost-Effectiveness
Med Decis Making,
May 1, 2001;
21(3):
219 - 230.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Briggs
Economic evaluation and clinical trials: size matters
BMJ,
December 2, 2000;
321(7273):
1362 - 1363.
[Full Text]
|
 |
|

|
 |

|
 |
 
E. M. Laska, M. Meisner, and C. Siegel
Power and Sample Size in Cost- Effectiveness Analysis
Med Decis Making,
August 1, 1999;
19(3):
339 - 343.
[Abstract]
[PDF]
|
 |
|
|
|